Last reviewed · How we verify
VCL-HB01
At a glance
| Generic name | VCL-HB01 |
|---|---|
| Sponsor | Vical |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy Study of Herpes Simplex Virus Type 2 (HSV-2) Therapeutic DNA Vaccine (PHASE2)
- Safety and Efficacy Trial of DNA Vaccines to Treat Genital Herpes in Adults (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- VCL-HB01 CI brief — competitive landscape report
- VCL-HB01 updates RSS · CI watch RSS
- Vical portfolio CI